modafinil has been researched along with Chronic Hepatitis C in 2 studies
Modafinil: A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS.
modafinil : A racemate comprising equimolar amounts of armodafinil and (S)-modafinil. A central nervous system stimulant, it is used for the treatment of sleeping disorders such as narcolepsy, obstructive sleep apnoea, and shift-work sleep disorder. The optical enantiomers of modafinil have similar pharmacological actions in animals.
2-[(diphenylmethyl)sulfinyl]acetamide : A sulfoxide that is dimethylsulfoxide in which two hydrogens attached to one of the methyl groups are replaced by phenyl groups, while one hydrogen attached to the other methyl group is replaced by a carbamoyl (aminocarbonyl) group.
Excerpt | Relevance | Reference |
---|---|---|
"Fatigue is prevalent among patients with hepatitis C virus (HCV) and with HIV/AIDS but there are no established fatigue treatments for either condition or their combination." | 6.76 | Modafinil and armodafinil treatment for fatigue for HIV-positive patients with and without chronic hepatitis C. ( McElhiney, MC; Rabkin, JG; Rabkin, R, 2011) |
"IFN-alpha-induced depression is presumed to be composed of two overlapping syndromes: a depression-specific syndrome characterized by depressed mood, anxiety, and cognitive complaints, and a neurovegetative syndrome consisting of fatigue, anorexia, somatic pain complaints, and psychomotor retardation [1]." | 5.34 | Modafinil's use in combating interferon-induced fatigue. ( Balan, V; Krahn, LE; Martin, KA; Rosati, MJ, 2007) |
"Fatigue is prevalent among patients with hepatitis C virus (HCV) and with HIV/AIDS but there are no established fatigue treatments for either condition or their combination." | 2.76 | Modafinil and armodafinil treatment for fatigue for HIV-positive patients with and without chronic hepatitis C. ( McElhiney, MC; Rabkin, JG; Rabkin, R, 2011) |
"IFN-alpha-induced depression is presumed to be composed of two overlapping syndromes: a depression-specific syndrome characterized by depressed mood, anxiety, and cognitive complaints, and a neurovegetative syndrome consisting of fatigue, anorexia, somatic pain complaints, and psychomotor retardation [1]." | 1.34 | Modafinil's use in combating interferon-induced fatigue. ( Balan, V; Krahn, LE; Martin, KA; Rosati, MJ, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rabkin, JG | 1 |
McElhiney, MC | 1 |
Rabkin, R | 1 |
Martin, KA | 1 |
Krahn, LE | 1 |
Balan, V | 1 |
Rosati, MJ | 1 |
1 trial available for modafinil and Chronic Hepatitis C
Article | Year |
---|---|
Modafinil and armodafinil treatment for fatigue for HIV-positive patients with and without chronic hepatitis C.
Topics: Adolescent; Adult; Aged; Benzhydryl Compounds; Central Nervous System Stimulants; Fatigue; Female; H | 2011 |
1 other study available for modafinil and Chronic Hepatitis C
Article | Year |
---|---|
Modafinil's use in combating interferon-induced fatigue.
Topics: Aged; Antiviral Agents; Benzhydryl Compounds; Central Nervous System Stimulants; Depression; Fatigue | 2007 |